ZA202311796B - Benzimidazole compound or salt thereof, canine filariasis control agent containing same, and method of use thereof - Google Patents

Benzimidazole compound or salt thereof, canine filariasis control agent containing same, and method of use thereof

Info

Publication number
ZA202311796B
ZA202311796B ZA2023/11796A ZA202311796A ZA202311796B ZA 202311796 B ZA202311796 B ZA 202311796B ZA 2023/11796 A ZA2023/11796 A ZA 2023/11796A ZA 202311796 A ZA202311796 A ZA 202311796A ZA 202311796 B ZA202311796 B ZA 202311796B
Authority
ZA
South Africa
Prior art keywords
salt
control agent
agent containing
containing same
benzimidazole compound
Prior art date
Application number
ZA2023/11796A
Other languages
English (en)
Inventor
Tanaka Ryosuke
Fujihara Hirokazu
Fuchi Shunsuke
Fukatsu Kosuke
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of ZA202311796B publication Critical patent/ZA202311796B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • A01N43/521,3-Diazoles; Hydrogenated 1,3-diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00Arthropodicides
    • A01P7/04Insecticides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Insects & Arthropods (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA2023/11796A 2021-06-02 2023-12-21 Benzimidazole compound or salt thereof, canine filariasis control agent containing same, and method of use thereof ZA202311796B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021092795 2021-06-02
JP2022021145 2022-02-15
PCT/JP2022/022536 WO2022255460A1 (ja) 2021-06-02 2022-06-02 ベンゾイミダゾール化合物又はその塩類及び該化合物を含有する犬糸状虫症防除剤並びにその使用方法

Publications (1)

Publication Number Publication Date
ZA202311796B true ZA202311796B (en) 2025-04-30

Family

ID=84324302

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2023/11796A ZA202311796B (en) 2021-06-02 2023-12-21 Benzimidazole compound or salt thereof, canine filariasis control agent containing same, and method of use thereof

Country Status (14)

Country Link
US (1) US20240270712A1 (https=)
EP (1) EP4349824A4 (https=)
JP (1) JP7700229B2 (https=)
KR (1) KR20240012540A (https=)
AU (1) AU2022286144A1 (https=)
BR (1) BR112023024371A2 (https=)
CA (1) CA3222199A1 (https=)
CL (1) CL2023003509A1 (https=)
CO (1) CO2023017613A2 (https=)
MX (1) MX2023014032A (https=)
PH (1) PH12023553295A1 (https=)
UA (1) UA130072C2 (https=)
WO (1) WO2022255460A1 (https=)
ZA (1) ZA202311796B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022016546A (es) * 2020-07-03 2023-02-01 Nihon Nohyaku Co Ltd Agente anticoccidio y metodo para su uso.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2682676A1 (en) * 2007-04-19 2008-10-30 Novartis Ag Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
US8691187B2 (en) 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
WO2012020725A1 (ja) 2010-08-10 2012-02-16 塩野義製薬株式会社 Npy y5受容体拮抗作用を有するヘテロ環誘導体
TWI652014B (zh) * 2013-09-13 2019-03-01 美商艾佛艾姆希公司 雜環取代之雙環唑殺蟲劑
UY37866A (es) * 2017-09-07 2019-03-29 Glaxosmithkline Ip Dev Ltd Nuevos compuestos derivados de benzoimidazol sustituidos que reducen la proteína myc (c-myc) en las células e inhiben la histona acetiltransferasa de p300/cbp.
CN108440396A (zh) * 2018-03-23 2018-08-24 吉林奥来德光电材料股份有限公司 一种有机发光材料及其制备方法和应用
EP3798212A4 (en) * 2018-05-22 2022-03-23 Nihon Nohyaku Co., Ltd. BENZIMIDAZOLE COMPOUND OR SALT THEREOF, INSECTICIDE AND ACARICIDE FOR AGRICULTURE AND HORTICULTURE WITH THIS COMPOUND AND METHODS OF USE
MX2022016546A (es) * 2020-07-03 2023-02-01 Nihon Nohyaku Co Ltd Agente anticoccidio y metodo para su uso.

Also Published As

Publication number Publication date
CO2023017613A2 (es) 2024-01-15
JPWO2022255460A1 (https=) 2022-12-08
WO2022255460A1 (ja) 2022-12-08
UA130072C2 (uk) 2025-10-29
KR20240012540A (ko) 2024-01-29
JP7700229B2 (ja) 2025-06-30
CA3222199A1 (en) 2022-12-08
MX2023014032A (es) 2023-12-15
BR112023024371A2 (pt) 2024-02-15
AU2022286144A1 (en) 2024-01-18
EP4349824A1 (en) 2024-04-10
CL2023003509A1 (es) 2024-05-17
US20240270712A1 (en) 2024-08-15
PH12023553295A1 (en) 2024-03-18
EP4349824A4 (en) 2024-10-16

Similar Documents

Publication Publication Date Title
MY190137A (en) Noxious organism control agent composition for agricultural and horticultural applications, and method for using said composition
EP3878282A4 (en) PEST CONTROL COMPOSITION AND METHODS OF USE THEREOF
PH12020500236B1 (en) Heterocyclic compound and use thereof
MX2015013798A (es) Derivados de bencimidazolona como inhibidores de bromodominio.
EP4174056A4 (en) ARYLTETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, INSECTICIDE THEREOF AND METHOD OF USE THEREOF
MX2010005997A (es) Derivados de aminobenzamida como agentes utiles para el control de parasitos de animales.
ZA202311796B (en) Benzimidazole compound or salt thereof, canine filariasis control agent containing same, and method of use thereof
EP4293015A4 (en) BENZIMIDAZOLE COMPOUND OR SALT THEREOF, MANUFACTURE PROCESS AND USE THEREOF, AND INSECTICIDE AND ACARICIDE AND USE THEREOF
IL274734A (en) A heterocyclic compound and an arthropod pest control agent containing it
EP4006024A4 (en) HETEROCYCLIC AMIDE COMPOUND, PROCESS THEREOF AND USE THEREOF
CO6650394A2 (es) Composición para controlar artrópodos dañinos y método para controlar artrópodos dañinos
MX2018001317A (es) Inhibidores del virus sincitial respiratorio.
ZA201908433B (en) Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compound
ZA202209676B (en) Method for rapidly evaluating exudation rate of antifouling agent in antifouling coating
ZA202311797B (en) Benzimidazole compound or salt thereof, canine filariasis control agent containing same, and method of use thereof
BR112023020274A2 (pt) Método de preparo de composto bicíclico e aplicação como agente antifúngico
EA201991570A1 (ru) Амидные соединения и их применение
EP3778583A4 (en) HETEROCYCLIC COMPOSITION AND ARTHROPODIC PEST CONTROL COMPOSITION WITH IT
IL262794A (en) An inhibitor of the expression of a pro-inflammatory factor, a masking method for its active component, a useful expression cassette for said method, a diagnostic factor and a diagnosis method
EP4169531A4 (en) MEDICINAL PRODUCT WITH ACTIVE SULFUR COMPOUND AS MAIN INGREDIENT
PH12020551154A1 (en) Method for suppressing discoloration of external composition containing adenosine phosphate and tranexamic acid
BRPI0920684A2 (pt) Composto, composição de composto ativo, semente, método para controlar fungos fitopatogênicos, medicamento, e, método para preparar um agente antimicótico
MX2019012786A (es) Compuesto de n-(4-piridil)nicotinamida o sal del mismo.
EP4029855A4 (en) ONIUM SALT OF NITROGEN-CONTAINING HETEROARYL COMPOUND AND PEST CONTROL AGENT
EP4056575A4 (en) IMIDAZOLIDINONE COMPOUND, PROCESS THEREOF AND USE THEREOF